Clinical Trial Update: Treatment of Low Dose IL-2 and Ganciclovir in Cytomegalovirus Infection [Phase 1, Phase 2]

View source ↗

Summary

Preliminary clinical trial update on low-dose IL-2 and ganciclovir for cytomegalovirus infections (Phase 1/Phase 2).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cytomegalovirus Infections

Drugs mentioned

• GANCICLOVIR (GANCICLOVIR SODIUM)
• Low-dose interleukin-2 (IL-2) (interleukin-2)

Snippet

Sponsor: Peking University People's Hospital | Conditions: Cytomegalovirus Infections | Phase 1, Phase 2 | Status: UNKNOWN